News

News 23.06.2025 June 19, 2025  - Zurich, Switzerland | Lisbon, Portugal Brenus Pharma, a French biotech developing next-generation first-in-class immunotherapies, and InSphero, a Swiss leader in 3D cell-based assay technologies, presented promising data at the European Association for Cancer Research 2025 annual congress. These data confirm the use of 3D tumor spheroids for potency testing of...

News 23.06.2025 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass. and PARIS, June 22, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”) and...

News 23.06.2025 The Physicians Committee for Responsible Medicine, a nonprofit that advances human-based science, and InSphero, a global leader in 3D in vitro technology for drug safety and efficacy testing, are pleased to offer the 2025 Human Advanced In Vitro Model Initiative (HUMAIN) Award. The HUMAIN Award recognizes researchers working to expand access to and accelerate the...

News 23.06.2025 Kuros Biosciences has announced Laura Rosa as its new Senior Vice President of Global Human Resources. With her 25 years of leadership experience in human resources, she will further develop the HR structure and promote talent development within the company. The Schlieren-based biotech company announced the appointment in a LinkedIn post....

News 12.06.2025 Schlieren / Zurich, Switzerland, 11 June, 2025 – Memo Therapeutics AG (or “MTx”), a late-stage biotechnology company developing antibody-based therapies for viral infections and cancer, has published a study in Frontiers in Pharmacology detailing the transport of therapeutic IgG1 antibodies across the kidney endothelial barrier. This quantitative analysis provides a scientific basis for the...